Clinical evaluation of open flap debridement with or without Emdogain® in treating intrabony defects

对采用或不采用 Emdogain® 进行开放式皮瓣清创术治疗骨内缺损的临床评价

阅读:2

Abstract

Periodontitis causes intrabony defects and while open flap debridement (OFD) with EMD and GTR shows promise, the comparative effectiveness of EMD in treating these defects remains underexplored. Open flap debridement (OFD) or access flap surgery is used in conjunction with biological factors such as enamel matrix derivative (EMD) and regenerative techniques involving guided tissue regeneration (GTR) in order to overcome these intrabony defects. In numerous clinical investigations, the application of EMD has demonstrated notable clinical improvements in bone fill clinical attachment gain and pocket depth reduction. Thus, the clinical effectiveness of open flap debridement with and without enamel matrix derivative (EMD) in treating periodontal intrabony defects, further exploring EMD's contribution to clinical outcomes such as bone fill, attachment gain and pocket depth reduction is reported.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。